This certificate confirms that Nasir Mustafa completed an online continuing medical education activity titled "State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers" on April 26, 2022. He was awarded 0.50 AMA PRA Category 1 credits for participating. Medscape, LLC jointly accredited by several medical organizations, designates this activity for a maximum of 0.50 credits.

1. 4/26/22, 3:57 PM CME Certificate for 'State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers'
https://www.medscape.org/activitytracker?view=true&resultId=88665600&search=true 1/2
CONTINUING MEDICAL EDUCATION CERTIFICATE
certifies that
NASIR MUSTAFA
34320
has participated in the enduring material titled
State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers
April 26, 2022
and is awarded 0.50
AMA PRA Category 1 Credit(s)™.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council
for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for
the healthcare team.
For information on applicability and acceptance of continuing education credit for this activity, please
consult your professional licensing board.
Certificate Number: 88665600
Kathleen N Geissel, PharmD
Group VP Operations
Medscape Education

2. 4/26/22, 3:57 PM CME Certificate for 'State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers'
https://www.medscape.org/activitytracker?view=true&resultId=88665600&search=true 2/2